Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Atypical Antipsychotics
100%
Neural Regulation
100%
Peripheral Metabolism
100%
Food Intake Regulation
100%
Weight Gain
37%
Food Intake
25%
Olanzapine
25%
Clozapine
25%
Increased Incidence
12%
Muscarinic Receptors
12%
Glucose-insulin System
12%
Consequences of Obesity
12%
Vagus Nerve
12%
Glucose Abnormalities
12%
Type 2 Diabetes Mellitus (T2DM)
12%
Fasting Insulin
12%
Metabolic Disease
12%
Fasting Triglycerides
12%
Metabolic Effects
12%
Body Adiposity
12%
Associated Weights
12%
Vicious Cycle
12%
Histaminergic
12%
Metabolic Impairment
12%
Histamine Receptors
12%
Fasting Blood Glucose
12%
Abnormal Glucose Metabolism
12%
Biochemistry, Genetics and Molecular Biology
Metabolic Pathway
100%
Atypical Antipsychotic
100%
Olanzapine
25%
Clozapine
25%
Glucose
25%
Cross Sectional Study
12%
Prospective Study
12%
Mediator
12%
Glucose Metabolism
12%
Triglyceride
12%
Metabolic Disorder
12%
Muscarinic Acetylcholine Receptor
12%
Histamine Receptor
12%
Histaminergic
12%
Maturity Onset Diabetes of the Young
12%
Insulin
12%
Neuroscience
Metabolic Pathway
100%
Atypical Antipsychotic
100%
Glucose
37%
Clozapine
25%
Olanzapine
25%
Diabetes Mellitus
12%
Metabolic Disorder
12%
Insulin
12%
Triacylglycerol
12%
Muscarinic Acetylcholine Receptor
12%
Vagus Nerve
12%
Histamine Receptor
12%
Pharmacology, Toxicology and Pharmaceutical Science
Atypical Antipsychotics
100%
Glucose
37%
Olanzapine
25%
Clozapine
25%
Cross Sectional Study
12%
Prospective Study
12%
Muscarinic Receptor
12%
Triacylglycerol
12%
Insulin
12%
Histamine Receptor
12%
Metabolic Disorder
12%
Maturity Onset Diabetes of the Young
12%